Considerations for SGLT2 inhibitor use in post-transplantation diabetes

被引：14

作者：

Hecking, Manfred ^{[1
]}

Jenssen, Trond ^{[2
,3
]}

机构：

[1] Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria

[2] Univ Hosp Oslo, Sect Nephrol, Dept Organ Transplantat, Oslo, Norway

[3] Univ Oslo, Oslo, Norway

来源：

NATURE REVIEWS NEPHROLOGY | 2019年 / 15卷 / 09期

关键词：

D O I：

10.1038/s41581-019-0173-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been recommended for the treatment of patients with type 2 diabetes mellitus and cardiovascular disease, heart failure or chronic kidney disease. Findings from recent efficacy and safety trials of empagliflozin in kidney transplant recipients with post-transplantation diabetes are timely, given the elevated cardiovascular risk associated with solid organ transplantation.

引用

页码：525 / 526

页数：2

共 6 条

[1]

Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]

[2] Renal, metabolic and cardiovascular considerations of SGLT2 inhibition [J].

DeFronzo, Ralph A. ;

Norton, Luke ;

Abdul-Ghani, Muhammad .

NATURE REVIEWS NEPHROLOGY, 2017, 13 (01) :11-26

[3] Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus [J].

Halden, Thea Anine Strom ;

Kvitne, Kine Eide ;

Midtvedt, Karsten ;

Rajakumar, Laavanyaah ;

Robertsen, Ida ;

Brox, Jan ;

Bollerslev, Jens ;

Hartmann, Anders ;

Asberg, Anders ;

Jenssen, Trond .

DIABETES CARE, 2019, 42 (06) :1067-1074

[4] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS [J].

Handelsman, Yehuda ;

Henry, Robert R. ;

Bloomgarden, Zachary T. ;

Dagogo-Jack, Sam ;

DeFronzo, Ralph A. ;

Einhorn, Daniel ;

Ferrannini, Ele ;

Fonseca, Vivian A. ;

Garber, Alan J. ;

Grunberger, George ;

LeRoith, Derek ;

Umpierrez, Guillermo E. ;

Weir, Matthew R. .

ENDOCRINE PRACTICE, 2016, 22 (06) :753-762

[5] Post-transplant diabetes mellitus in patients with solid organ transplants [J].

Jenssen, Trond ;

Hartmann, Anders .

NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (03) :172-188

[6] Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety [J].

Schwaiger, Elisabeth ;

Burghart, Lukas ;

Signorini, Lorenzo ;

Ristl, Robin ;

Kopecky, Chantal ;

Tura, Andrea ;

Pacini, Giovanni ;

Wrba, Thomas ;

Antlanger, Marlies ;

Schmaldienst, Sabine ;

Werzowa, Johannes ;

Saeemann, Marcus D. ;

Hecking, Manfred .

AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (03) :907-919

← 1 →